U.S. markets open in 7 hours 34 minutes

Scholar Rock Holding Corporation (SRRK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.30+0.23 (+1.63%)
At close: 4:00PM EDT

Scholar Rock Holding Corporation

620 Memorial Drive
2nd Floor
Cambridge, MA 02139
United States
857 259 3860

Full Time Employees93

Key Executives

NameTitlePayExercisedYear Born
Mr. Edward H. MylesCFO & Head of Bus. Operations55kN/A1972
Dr. Alan J. BucklerChief Scientific Officer542.61kN/A1960
Dr. Yung H. Chyung M.D.Chief Medical Officer564.11kN/A1976
Mr. Stuart Anthony Kingsley M.B.A., MBAPres, CEO & DirectorN/AN/A1964
Ms. Catherine HuVP of Investor Relations & Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, a novel inhibitor of the activation of myostatin, which is in Phase II clinical trials for the treatment of spinal muscular atrophy. The company is also developing SRK-181, which is in Phase I clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1. In addition, it is developing a pipeline of novel product candidates for a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Scholar Rock Holding Corporation’s ISS Governance QualityScore as of December 8, 2019 is 8. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.